What Are the Possible Side Effects of Weight Loss Injections?

Weight loss injections have started to be discussed more frequently in weight management, especially with the spread of medicines that act through GLP-1 and similar mechanisms. Although medicine names such as Wegovy, Ozempic, and Mounjaro are mentioned together in society under the heading of “weight loss injection,” the intended uses, active ingredients, doses, licensing information, and side effect profiles of these medicines may differ. Therefore, when evaluating side effects, it is important for which purpose, in whom, and with which medical follow-up plan the medicine is used.

The side effects of weight loss injections may vary from person to person. While some people may experience more manageable complaints such as mild nausea or decreased appetite, others may experience vomiting, diarrhea, constipation, abdominal pain, dehydration, low blood sugar, or conditions that require more serious follow-up. FDA product information for medicines such as Ozempic, Wegovy, and Mounjaro includes information about gastrointestinal side effects, pancreatitis warnings, gallbladder problems, kidney function-related warnings, and certain special risk groups.

Why Can Weight Loss Injections Cause Side Effects?

Some of the medicines known as weight loss injections affect systems in the body related to appetite, satiety, gastric emptying, and blood sugar regulation. These medicines may slow gastric emptying, increase the feeling of fullness, and reduce appetite in some people. This effect may be useful for weight management; however, the same mechanism may also underlie side effects such as nausea, indigestion, vomiting, diarrhea, or constipation.

The risk of side effects is not only related to the medicine itself. The person’s age, weight, diabetes status, kidney functions, gallbladder history, history of pancreatitis, gastrointestinal diseases, other medicines used, and dose escalation speed may also affect the likelihood of side effects. Therefore, the use of weight loss injections requires individualized medical evaluation.

Factors that may affect weight loss injection side effects are:

• Active ingredient of the medicine
• Starting dose
• Dose escalation speed
• The person’s gastrointestinal sensitivity
• Presence of diabetes or insulin resistance
• Other diabetes medicines used
• Kidney functions
• Gallbladder and pancreas history
• Dietary pattern
• Fluid intake
• Risk of counterfeit or unlicensed products
• Use without physician follow-up

Therefore, the side effect experience may be different in two people using the same medicine. A process that remains limited to mild nausea in one person may turn into a picture requiring more significant vomiting, dehydration, or dose adjustment in another person.

The Most Common Side Effects of Weight Loss Injections

The most commonly reported side effects of weight loss injections are generally related to the stomach and intestinal system. Nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, bloating, and reflux-like complaints may be felt more often especially at the beginning of treatment or after dose escalation. In FDA Wegovy product information, gastrointestinal side effects such as nausea, diarrhea, vomiting, constipation, and abdominal pain stand out; Mounjaro product information similarly draws attention to gastrointestinal system-related complaints.

Most of these side effects may be mild or moderate; however, they should always be taken seriously. Especially if complaints last long, lead to dehydration, or significantly impair the person’s nutrition, physician evaluation is needed. It is not safe to consider side effects “normal” and continue increasing the dose.

Nausea

Nausea is one of the side effects most commonly associated with weight loss injections. The medicine slowing gastric emptying and increasing the feeling of fullness may cause stomach discomfort in some people. Nausea may usually be felt more noticeably at the beginning of treatment or after dose escalation.

To reduce nausea, reducing meal portions, avoiding very fatty and heavy foods, eating slowly, and taking enough fluids may be supportive. However, if nausea is severe, affects daily life, or progresses with vomiting, the person should consult a physician instead of looking for a solution on their own.

Vomiting

Vomiting may occur especially when nausea becomes more severe. Repeated vomiting may lead to dehydration, electrolyte imbalance, weakness, and in some people, kidney function being affected. FDA product information states that kidney function should be monitored in side effects that may lead to volume depletion.

While using a weight loss injection, if vomiting repeats several times, if the person cannot take fluids, or if dizziness or a decrease in urine amount develops, a healthcare professional should be consulted. These symptoms should not be seen only as the process of getting used to the medicine.

Diarrhea

Diarrhea may be seen in some people at the beginning of treatment or after dose escalation. Mild diarrhea may improve in a short time; however, long-lasting or frequently recurring diarrhea is important in terms of dehydration. It is necessary to be more careful especially in older adults, people with kidney disease, or those using additional medicines due to diabetes.

When diarrhea develops, it is important to increase fluid intake, avoid heavy and fatty foods, and monitor the duration of the complaint. If bloody diarrhea, fever, severe abdominal pain, or significant weakness accompanies it, evaluation should not be delayed.

Constipation

Constipation is also one of the side effects that may be seen with weight loss injections. Slowing of stomach and bowel movements, eating less due to decreased appetite, low fluid intake, and a diet poor in fiber may increase constipation. While constipation may be mild in some people, abdominal bloating and discomfort may become more noticeable in others.

Adequate fluid consumption, a balanced fiber intake, and physical activity suitable for the person’s condition may be supportive to prevent constipation. However, if constipation lasts long, severe abdominal pain, vomiting, or significant difficulty with stool passage is present, physician evaluation is important.

Abdominal Pain and Indigestion

Abdominal pain, indigestion, bloating, and reflux-like complaints may be seen in some people. These symptoms may often be related to the gastrointestinal system’s response to the medicine. However, the severity, duration, and accompanying symptoms of abdominal pain should be evaluated carefully.

Especially abdominal pain that radiates to the back, is severe, persistent, or occurs with vomiting may suggest problems related to the pancreas or gallbladder. In such a situation, instead of continuing the medicine and waiting, medical support should be obtained quickly.

What Are the More Serious Side Effects?

Although serious side effects of weight loss injections are seen less frequently, they are one of the most important headings in the treatment decision. FDA and TİTCK product information for GLP-1-related medicines includes warnings such as acute pancreatitis, gallbladder diseases, serious gastrointestinal reactions, impaired kidney function due to dehydration, hypoglycemia, and serious allergic reactions.

These risks are not at the same level for everyone. The person’s medical history, other medicines used, diabetes status, and accompanying diseases may change the risk level. Therefore, weight loss injections are not medicines to be started without a physician or used only with social media advice.

Pancreatitis Risk

Pancreatitis is inflammation of the pancreas and is one of the warnings that should be taken seriously in people using weight loss injections. FDA product information states that acute pancreatitis has been observed with GLP-1 receptor agonists and that evaluation should be made by discontinuing the medicine if pancreatitis is suspected.

Symptoms to watch for in terms of pancreatitis are:

• Severe and persistent abdominal pain
• Abdominal pain radiating to the back
• Repeated vomiting
• Fever or deterioration in general condition
• Abdominal discomfort that increases with eating
• Sudden onset of intense gastrointestinal complaints

If these symptoms develop, the person should not continue the medicine on their own and should consult a healthcare professional. Suspicion of pancreatitis is a condition that should be evaluated without wasting time.

Gallbladder Problems

Gallbladder problems may come into consideration in some people during the weight loss process. Product information for GLP-1-related medicines includes warnings regarding acute gallbladder diseases. Conditions such as gallstones or gallbladder inflammation may present with abdominal pain, nausea, vomiting, and digestive complaints.

Symptoms to watch for in terms of gallbladder are:

• Pain in the upper right abdomen
• Pain that increases after fatty meals
• Nausea and vomiting
• Fever
• Jaundice
• Dark urine
• Pale stool

If these symptoms are present, it is not appropriate for the person to continue the weight loss injection on their own. Medical evaluation should be made and, if necessary, the medicine plan should be reviewed.

Kidney Function Being Affected

It cannot be said that weight loss injections directly cause kidney problems in every person; however, if vomiting, diarrhea, and dehydration develop, kidney functions may be affected. FDA Wegovy and Mounjaro product information states that kidney function should be monitored in people reporting reactions that may lead to volume depletion.

Symptoms to watch for in terms of kidney functions are:

• Significant decrease in urine amount
• Dry mouth
• Dizziness
• Severe weakness
• Long-lasting vomiting or diarrhea
• Inability to take fluids
• Confusion or significant grogginess

These symptoms should be monitored more carefully especially in people with kidney disease, older adults, or those using blood pressure and diabetes medicines.

Low Blood Sugar

When weight loss injections are used together with some diabetes medicines, they may increase the risk of low blood sugar. It is necessary to be more careful especially when used together with insulin or medicines that increase insulin secretion. FDA Mounjaro and Ozempic product information includes warnings on this issue.

Symptoms of low blood sugar may include:

• Sweating
• Trembling
• Palpitations
• Sudden hunger
• Dizziness
• Blurred vision
• Irritability
• Weakness
• Confusion

The use of weight loss injections in people with diabetes must be planned by an endocrinologist. Blood sugar monitoring, the dose of current medicines, and dietary pattern should be evaluated together.

Allergic Reactions

Serious allergic reactions may be rare; however, they must be known in terms of medicine safety. FDA product information includes warnings regarding serious hypersensitivity reactions for Ozempic, Wegovy, and Mounjaro.

Symptoms to watch for in terms of allergic reaction are:

• Swelling of the face, lips, tongue, or throat
• Shortness of breath
• Widespread rash
• Severe itching
• Dizziness
• Feeling faint

These symptoms may require urgent evaluation. If a person experiences such a picture, they must obtain medical support before using the medicine again.

Why Are Thyroid-Related Warnings Important?

Some weight loss injections’ product information includes warnings about thyroid C-cell tumors. These warnings are especially important for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome known as MEN 2. FDA Mounjaro product information states that the medicine should not be used in these conditions.

This warning does not mean that everyone who uses this medicine will develop thyroid cancer. However, it shows that weight loss injections should not be started without knowing the person’s thyroid history and family history. Therefore, endocrinological evaluation is especially important.

Points to be evaluated in terms of thyroid are:

• Family history of medullary thyroid cancer
• Personal history of thyroid cancer
• Diagnosis or suspicion of MEN 2
• Lump or swelling in the neck
• Hoarseness
• Difficulty swallowing
• Unexplained symptoms in the neck area

If these symptoms or histories are present, the person must consult an endocrinologist before using weight loss injections.

In Whom Can Side Effects Be Riskier?

Weight loss injections do not show the same effect and side effect profile in every person. Closer follow-up may be required in some people. Especially those with diabetes, those using insulin, those with kidney disease, those with a history of gallstones, people who have had pancreatitis, those with serious gastrointestinal disease, and those planning pregnancy should be evaluated more carefully.

Even if these medicines come into consideration for weight management, starting them without evaluating the person’s general health status is not appropriate. Because side effect risk is often not only related to the medicine, but also to the person’s current health status and other medicines used.

Groups that should be evaluated more carefully are:

• People with type 2 diabetes
• Those using insulin or sulfonylurea
• Those with kidney disease
• Those who have previously had pancreatitis
• Those with gallstones or gallbladder disease
• Those with a history of severe reflux or gastroparesis
• Those with a history of thyroid cancer or MEN 2
• Pregnant people or those planning pregnancy
• Breastfeeding people
• Those experiencing very rapid weight loss
• Those following a very low-calorie diet
• Those using multiple medicines

In these groups, the treatment decision should be individualized. Starting without physician evaluation, changing the dose, or using the medicine for different purposes may be risky.

Do Counterfeit or Unlicensed Weight Loss Injections Increase Side Effect Risk?

Yes. Counterfeit, unlicensed, or unknown-source weight loss injections may pose serious risks. These products may contain no active ingredient, contain the wrong dose, or contain different or harmful substances. The FDA has published its concerns about the use of unapproved GLP-1 medicines for weight loss; it stated that semaglutide and tirzepatide products illegally marketed online may be counterfeit and may contain wrong or harmful ingredients.

The World Health Organization has also issued a medical product alert about falsified semaglutide products and emphasized that such products should be obtained from authorized, licensed suppliers.

Risks with counterfeit or unlicensed products may include:

• Receiving the wrong dose
• Not receiving the active ingredient
• Receiving an excessive dose
• Exposure to harmful ingredients
• Risk of injection-related infection
• Unexpected side effects
• Treatment failure
• Blood sugar imbalances
• Reactions requiring urgent intervention

Therefore, weight loss injections should only be used after physician evaluation and through reliable and legal medicine supply channels. Products obtained through social media, internet advertisements, or personal recommendations may pose serious health risks.

What Should Be Done If Side Effects Develop?

If side effects develop while using weight loss injections, the first step is to correctly evaluate the type and severity of the complaint. Symptoms such as mild nausea or temporary decrease in appetite may be monitored; however, a physician should be consulted for severe, repetitive, or daily life-affecting side effects. The FDA MedWatch system is an official safety reporting channel for reporting serious side effects, product quality problems, use errors, or suspected counterfeit products.

In general, the following steps should be followed when side effects develop:

• Not increasing the medicine on one’s own
• Not changing the dose on one’s own
• Noting when the complaint started
• Monitoring the duration of symptoms such as vomiting, diarrhea, and abdominal pain
• Paying attention to fluid intake
• Increasing blood sugar monitoring if diabetes is present
• Consulting a healthcare professional in severe symptoms
• Not using the product if counterfeit product is suspected
• Informing the physician about all medicines used

In this process, whether the medicine will be continued, whether the dose will be changed, or whether a different evaluation is needed should be determined by the physician.

How Can Weight Loss Injection Side Effects Be Reduced?

It may not always be possible to completely prevent side effects; however, correct initiation, appropriate dose escalation, dietary pattern, and regular follow-up may make side effect management easier. During the treatment process, the person should focus not only on weight loss but also on general health status.

Approaches that may help reduce the risk of side effects are:

• Starting the medicine with physician evaluation
• Making dose increases according to the physician’s plan
• Avoiding heavy and fatty meals
• Reducing portions
• Eating slowly
• Taking enough fluids
• Paying attention to fiber balance against constipation
• Not aiming for very rapid weight loss
• Monitoring blood sugar if used together with diabetes medicines
• Not neglecting severe abdominal pain
• Not using counterfeit or unlicensed products
• Sharing side effects in regular follow-up appointments

These recommendations are for general informational purposes. Since each person’s health status is different, side effect management should be planned individually. Endocrinology follow-up is especially important in terms of evaluating both the suitability of the medicine and the risks during the treatment process.

Weight Loss Injection Side Effects Should Not Be Underestimated

Although weight loss injection side effects often begin with the stomach and intestinal system, in some cases they may require more serious follow-up in terms of the pancreas, gallbladder, kidney functions, blood sugar balance, and allergic reactions. Therefore, weight loss injections should be addressed not only with the goal of weight loss, but also together with general health safety.

When making decisions about GLP1, Wegovy, Mounjaro, Ozempic, or similar medicines, it is not safe for a person to use medicines on their own, increase the dose, or act according to social media advice. The most appropriate approach is to plan the necessity, suitability, and side effect risks of the medicine with an endocrinologist’s evaluation.

Access Online Endocrinology Doctor Support With Happ Health

Weight loss injection side effects may not consist only of simple complaints such as nausea or decreased appetite. The person’s diabetes status, thyroid history, pancreas and gallbladder risks, kidney functions, medicines used, and weight management goals should be evaluated together.

Happ Health, with its digital health platform approach, offers a solution that makes access to Online Endocrinology Doctor support easier. You can evaluate whether GLP1, Wegovy, Mounjaro, Ozempic, or similar medicines are suitable for you, how possible side effects should be monitored, and which steps may be safer in the weight management process with expert opinion within the scope of remote healthcare service.

References

• U.S. Food and Drug Administration. Ozempic Prescribing Information.
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s025lbl.pdf
• U.S. Food and Drug Administration. Wegovy Prescribing Information.
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s026lbl.pdf
• U.S. Food and Drug Administration. Mounjaro Prescribing Information.
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s039lbl.pdf
• U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
  https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
• U.S. Food and Drug Administration. MedWatch: FDA Safety Information and Adverse Event Reporting Program.
  https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
• World Health Organization. Medical Product Alert N°2/2024: Falsified OZEMPIC (semaglutide).
  https://www.who.int/news/item/19-06-2024-medical-product-alert-n-2-2024--falsified-ozempic-%28semaglutide%29
• World Health Organization. WHO issues warning on falsified medicines used for diabetes treatment and weight loss.
  https://www.who.int/news/item/20-06-2024-who-issues-warning-on-falsified-medicines-used-for-diabetes-treatment-and-weight-loss
• Turkish Medicines and Medical Devices Agency. Ozempic Summary of Product Characteristics.
  https://www.titck.gov.tr/storage/Archive/2023/kubKtAttachments/ozempic0.5kubtemiz_ac5c5506-4191-4f47-8ed4-c9b36dec0055.pdf
• Turkish Medicines and Medical Devices Agency. Mounjaro Patient Information Leaflet.
  https://www.titck.gov.tr/storage/Archive/2025/kubKtAttachments/MOUNJARO10KTONAY_31_10_2025.pdf